XML 217 R62.htm IDEA: XBRL DOCUMENT v3.25.0.1
Related Parties (Tables)
12 Months Ended
Jun. 30, 2024
Related Parties [Abstract]  
Schedule of Key Management Personnel Compensation Comprised

Key management personnel compensation comprised:

In USD ($)

 

June 30,
2024

 

June 30,
2023

 

June 30,
2022

Short-term employee benefits

 

621,330

 

39,250

 

96,437

Share based payment

 

529,397

 

904,861

 

838,576

Schedule of Other Related Party Transactions

Other Related Party Transactions

In USD ($)

 

Note

 

For the year
ended
June 30,

2024

 

For the year
ended
June 30,

2023

 

For the year
ended
June 30,

2022

Share based payment

               

Key management

     

529,397

 

904,861

 

838,576

CFO Shares Alloted

     

 

364,014

 

Issue of additional shares

               

Issue of share capital

     

 

15,000

 

Issue of share premium

     

 

39,610,630

 

Expenses paid on behalf of the company

               

Parent of BG Farming Technologies – Bioceres S.A.

     

 

 

265,810

100% Subsidiary of Bioceres S.A. – Bioceres LLC

 

(i)

 

 

238,121

 

156,760

Services provided by other companies

     

       

Bioceres Crop Solutions Corp

 

(ii)

 

7,600,000

 

 

Invim Corporativo S.L.

 

(iii)

 

10,000,000

 

 

30% owned by Bioceres S.A. – INMET S.A. – Ingenieria Metabolica S.A.

 

(iv)

 

26,745

 

286

 

252

98.6% owned by Bioceres S.A – INDEAR S.A. –Instituto de Agrobiotecnologia Rosario

 

(v)

 

49,805

 

258,279

 

57,047

Owned by Bioceres S.A. – Agrality Inc.

 

(vi)

 

 

5,000

 

85,435

Founded and operated by the Company’s CPO – Future Foods B.V.

 

(vii)

 

48,780

 

85,880

 

94,857

Union Group Ventures Limited

 

(viii)

 

 

 

675,000

THEO I SCSp

     

 

 

1,500,000

(i)      Expenses paid by Bioceres LLC on behalf of the Company.

(ii)     On June 14, 2024, Moolec Science SA and Bioceres Crop Solutions Corp. (“BIOX”) signed an agreement under which BIOX sold 15,000 tons of HB4 soybean to Moolec Science SA for an amount of USD 6,600,000 payable in 2026. Later, on September 15, 2024 such payables were exchanged for a convertible note (see note 31). Additionally, on June 29, 2024, Moolec Science SA entered into an exclusive Technology Access License Agreement with BIOX for USD 1,000,000, granting Moolec science SA the right to use BIOX’s HB4 technology for a period of 5 years.

(iii)    On October 15, 2023, Moolec Science has entered into an agreement to issue a convertible note due 2026 to Invim Corporativo S.L. As of June 30, 2024, the Company has received USD 10,000,000 related to such convertible note.

(iv)    The Company entered into an agreement with INMET S.A. — Ingenieria Metabolica S,A through which it would receive research services in exchange for payment.

(v)      The Company entered into an agreement with INDEAR S.A. — Instituto de Agrobiotecnologia Rosario where it would receive research services in exchange for payment.

(vi)    The Company entered into an agreement with Agrality Inc, for the provision of services.

(vii)   The Company entered into an agreement with Future Foods B.V. for the provision of services.

(viii)  The Company entered into an agreement with Union Group Ventures Limited which accrues an interest expense.

Schedule of Other Related Party Balances

Other Related Party Balances

In USD ($)

 

Balance
outstanding

as of
June 30,

2024

 

Balance
outstanding

as of
June 30,

2023

Bioceres Crop Solutions Corp

 

(7,600,000

)

 

 

100% Subsidiary of Bioceres S.A. – Bioceres LLC

 

(491,894

)

 

(623,629

)

Invim Corporativo S.L.

 

(10,572,772

)

 

 

Union Group Ventures Limited

 

(794,301

)

 

(677,000

)

Founded and operated by the Company’s CPO – Future Foods B.V.

 

(47,199

)

 

(78,337

)

Agrality Inc.

 

(26,750

)

 

 

INDEAR S.A.

 

(2,992

)

 

(72,494

)